Carcinoma In Situ — Trials

Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

274 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 35
Ph III recruiting: 4
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (41)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03317405	Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	active not recruiting	Phase 1	32	National Cancer Institute (NCI)NIH	1	Sep 2, 2026	clinicaltrials
NCT05340673	Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer	active not recruiting	Phase 1	208	City of Hope Medical CenterOTHER	1	Aug 17, 2026	clinicaltrials